Karen Bernstein
CIK 1654055 · last filed 2026-03-02
Karen Bernstein is a corporate insider who has filed 26 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for OVID, was dated Mar 2, 2026. Across all open-market trades the lifetime net is +$82.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $46.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$46.0K
4
26
$82.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OVID | Director | 20,000 | $2.30 | $46.0K | $82.5K | 16 | 2026-03-02 |
| Codiak BioSciences, Inc. (CDAK) Delisted | Director | 8,750 | $0.06 | $499 | $0 | 5 | 2023-02-21 |
| Achaogen, Inc. (AKAO) Delisted | Director | — | — | — | $0 | 2 | 2018-06-07 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Director | — | — | — | $0 | 3 | 2016-10-25 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-02 | OVID | Grant (A) | — | $0 | EDGAR |
| 2025-06-18 | OVID | Grant (A) | — | $0 | EDGAR |
| 2024-12-16 | OVID | Grant (A) | — | $0 | EDGAR |
| 2024-02-26 | OVID | Grant (A) | — | $0 | EDGAR |
| 2023-02-27 | OVID | Grant (A) | — | $0 | EDGAR |
| 2023-02-21 | Codiak BioSciences, Inc. (CDAK) Delisted | Exer (M) | +8,750 | $0 | EDGAR |
| 2022-06-21 | Codiak BioSciences, Inc. (CDAK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-12 | OVID | Grant (A) | — | $0 | EDGAR |
| 2022-02-18 | Codiak BioSciences, Inc. (CDAK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-04 | OVID | Grant (A) | — | $0 | EDGAR |